Georg Nickenig News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Georg nickenig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Georg Nickenig Today - Breaking & Trending Today
Men and women with severe tricuspid regurgitation have similar rates of procedural success and 2-year survival after transcatheter tricuspid valve intervention, despite significant differences in cardiac volumetrics and comorbidities.“Although female sex is generally recognized as a risk factor for hospital mortality and is, thus, included in surgical risk scores used by interdisciplinary ....
New results demonstrate MitraClip transcatheter edge-to-edge repair (TEER) is effective at treating leaky valves in people with secondary mitral regurgitation (MR) ....
May 21, 2021 Transcatheter therapies for tricuspid valve disease continue to gain momentum, as evidenced by three studies presented at this week’s EuroPCR 2021: TRISCEND, TriBAND, and CLASP TR. On the whole, the early data suggest these devices are a viable treatment for tricuspid regurgitation (TR), investigators told the meeting’s virtual audience, yet they also speak to the diverse approaches annular reduction, transcatheter edge-to-edge repair (TEER), and valve replacement aimed at addressing this clinical niche. All three are manufactured by Edwards Lifesciences: Thirty-day data from TRISCEND make the case for valve replacement, specifically with the Evoque device, in patients with symptomatic and at least moderate TR. ....